to provide GMP storage for a 4-valent synthetic O-antigen-based Shigella glycoconjugate vaccine developed to prevent morbidity and mortality due to shigellosis in infants and children in low- and ...
I really can’t comment on how enjoyable a mud bath might be. I’ve fallen in the mud a time or two, and fell in some more questionable substances back when I had horses, but I’ve never taken a mud bath ...
In 1989 he founded and became the director of the Insitut Pasteur’s Molecular Microbial Pathogenesis Unit. He is Professor of Microbiology and Infectious Diseases at the Collège de France. He has ...
Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part ...